Tuberculosis pleural asociada con adalimumab, en un paciente con artritis reumatoide

Tuberculosis (TB) represents one of the endemic infectious diseases in our population. The incidence of reactivate TB cases has grown notoriously with the onset of new therapeutic options for controlling rheumatoid arthritis (RA), such as tumor necrosis factor (TNF) inhibitors.